125 related articles for article (PubMed ID: 24900265)
21. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
22. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization.
Nasser MW; Raghuwanshi SK; Malloy KM; Gangavarapu P; Shim JY; Rajarathnam K; Richardson RM
J Biol Chem; 2007 Mar; 282(9):6906-15. PubMed ID: 17204468
[TBL] [Abstract][Full Text] [Related]
23. Diverging mechanisms of activation of chemokine receptors revealed by novel chemokine agonists.
Sarmiento J; Shumate C; Suetomi K; Ravindran A; Villegas L; Rajarathnam K; Navarro J
PLoS One; 2011; 6(12):e27967. PubMed ID: 22174759
[TBL] [Abstract][Full Text] [Related]
24. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.
Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386
[TBL] [Abstract][Full Text] [Related]
25. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
[TBL] [Abstract][Full Text] [Related]
26. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
[TBL] [Abstract][Full Text] [Related]
27. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
Joseph PRB; Sawant KV; Rajarathnam K
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
[TBL] [Abstract][Full Text] [Related]
28. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
[TBL] [Abstract][Full Text] [Related]
29. Elucidation of Distinct Roles of Guinea Pig CXCR1 and CXCR2 in Neutrophil Migration toward IL-8 and GROα by Specific Antibodies.
Tanaka K; Yoshitomi T; Hirahara K
Biol Pharm Bull; 2017; 40(5):729-732. PubMed ID: 28458362
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2.
Casilli F; Bianchini A; Gloaguen I; Biordi L; Alesse E; Festuccia C; Cavalieri B; Strippoli R; Cervellera MN; Di Bitondo R; Ferretti E; Mainiero F; Bizzarri C; Colotta F; Bertini R
Biochem Pharmacol; 2005 Feb; 69(3):385-94. PubMed ID: 15652230
[TBL] [Abstract][Full Text] [Related]
31. Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.
Maeda DY; Quinn MT; Schepetkin IA; Kirpotina LN; Zebala JA
J Pharmacol Exp Ther; 2010 Jan; 332(1):145-52. PubMed ID: 19779130
[TBL] [Abstract][Full Text] [Related]
32. Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8.
Fan X; Patera AC; Pong-Kennedy A; Deno G; Gonsiorek W; Manfra DJ; Vassileva G; Zeng M; Jackson C; Sullivan L; Sharif-Rodriguez W; Opdenakker G; Van Damme J; Hedrick JA; Lundell D; Lira SA; Hipkin RW
J Biol Chem; 2007 Apr; 282(16):11658-66. PubMed ID: 17197447
[TBL] [Abstract][Full Text] [Related]
33. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2.
Aul R; Patel S; Summerhill S; Kilty I; Plumb J; Singh D
Int Immunopharmacol; 2012 Jul; 13(3):225-31. PubMed ID: 22561413
[TBL] [Abstract][Full Text] [Related]
34. Cross-desensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon.
Nasser MW; Marjoram RJ; Brown SL; Richardson RM
J Immunol; 2005 Jun; 174(11):6927-33. PubMed ID: 15905535
[TBL] [Abstract][Full Text] [Related]
35. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M
J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203
[TBL] [Abstract][Full Text] [Related]
36. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
37. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils.
Hauser CJ; Fekete Z; Goodman ER; Kleinstein E; Livingston DH; Deitch EA
Shock; 1999 Dec; 12(6):428-37. PubMed ID: 10588510
[TBL] [Abstract][Full Text] [Related]
38. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.
Khandaker MH; Mitchell G; Xu L; Andrews JD; Singh R; Leung H; Madrenas J; Ferguson SS; Feldman RD; Kelvin DJ
Blood; 1999 Apr; 93(7):2173-85. PubMed ID: 10090924
[TBL] [Abstract][Full Text] [Related]
39. CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders.
Mamik MK; Ghorpade A
Curr Drug Targets; 2016; 17(1):111-21. PubMed ID: 26112047
[TBL] [Abstract][Full Text] [Related]
40. Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.
Ravindran A; Sawant KV; Sarmiento J; Navarro J; Rajarathnam K
J Biol Chem; 2013 Apr; 288(17):12244-52. PubMed ID: 23479735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
